Obesity

Adults with obesity and type 2 diabetes had reductions in body weight and HbA1c 1 year after undergoing an endoscopic procedure that resurfaces the duodenum lining, according to top-line results from a real-world registry study.

Pemvidutide, a glucagon-like peptide-1/glucagon dual receptor agonist, lowered liver fat content, markers of inflammation and body weight in patients with metabolic dysfunction-associated steatotic liver disease and obesity, research showed.

High-quality CT and stress testing should be able to effectively and safely diagnose patients with stable chest pain and suspected CAD, regardless of BMI, while improving clinical efficiency, researchers reported.

Adults using a GLP-1 receptor agonist do not have increased risk for nonarteritic anterior ischemic optic neuropathy, according to data from a retrospective analysis published in Journal of Diabetes Science and Technology.

In the U.S., diabetic ketoacidosis frequency at prenatal and delivery hospitalizations increased from 2010 to 2020 for mothers with pregestational diabetes, according to study results published in Obstetrics & Gynecology.

Tirzepatide significantly reduced HF outcomes and symptoms for patients with HF and preserved ejection fraction and obesity, according to the top-line results of the phase 3 SUMMIT clinical trial.